Kumarasamy, V., Wang, J., Roti, M., Wan, Y., Dommer, A. P., Rosenheck, H., . . . Knudsen, E. S. Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle. Nature Portfolio.
Chicago Style (17th ed.) CitationKumarasamy, Vishnu, et al. Discrete Vulnerability to Pharmacological CDK2 Inhibition Is Governed by Heterogeneity of the Cancer Cell Cycle. Nature Portfolio.
MLA (9th ed.) CitationKumarasamy, Vishnu, et al. Discrete Vulnerability to Pharmacological CDK2 Inhibition Is Governed by Heterogeneity of the Cancer Cell Cycle. Nature Portfolio.
Warning: These citations may not always be 100% accurate.